By signing the Copyright Letter the authors retain the rights of self-archiving. Following are the important features of self-archiving policy of Bentham Science journals:
Authors can deposit the first draft of a submitted article on their personal websites, their institution’s repositories or any non-commercial repository for personal use, internal institutional use or for permitted scholarly posting.
Authors may deposit the ACCEPTED VERSION of the peer-reviewed article on their personal websites, their institution’s repository or any non-commercial repository such as PMC, arXiv after 12 MONTHS of publication on the journal website. In addition, an acknowledgement must be given to the original source of publication and a link should be inserted to the published article on the journal's/publisher’s website.
If the research is funded by NIH, Wellcome Trust or any other Open Access Mandate, authors are allowed the archiving of published version of manuscripts in an institutional repository after the mandatory embargo period. Authors should first contact the Editorial Office of the journal for information about depositing a copy of the manuscript to a repository. Consistent with the copyright agreement, Bentham Science does not allow archiving of FINAL PUBLISHED VERSION of manuscripts.
The link to the original source of publication should be provided by inserting the DOI number of the article in the following sentence: “The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/openurl/content.php?genre=article&doi=[insert DOI].”
There is no embargo on the archiving of articles published under the OPEN ACCESS PLUS category. Authors are allowed deposition of such articles on institutional, non-commercial repositories and personal websites immediately after publication on the journal website.
Robert Powers University of Nebraska-Lincoln Lincoln, NE USA
Dr. Robert Powers is currently a Professor of Chemistry at the University of Nebraska-Lincoln. He has more than 30 years of experience in NMR spectroscopy, structural biology, metabolomics, and drug discovery. He received his BA from Rutgers University, a Ph.D. in chemistry fromt Purdue University, and was a postdoctoral fellow at the NIH laboratory of Chemical Physics. Prior to arriving at UNL, Dr. Powers was an Associate Director for the Protein NMR group at Wyeth. Dr. Powers is the Editor-in-Chief of Current Metabolomics and has written over 120 peer-reviewed manuscripts, 5 book chapters, and is an inventor on 9 patents.
Dave Watson BSc PhD PGCE is a reader in Pharmaceutical Sciences at the University of Strathclyde up He has specialised in chromatographic methods combined with mass spectrometry which he has applied to a range of problems ranging from drug metabolism and disposition through to metabolomics. He published a popular undergraduate textbook on Pharmaceutical Analysis textbook on Pharmaceutical Chemistry. He has been first supervisor for 45 completed PhD students and currently has a group of 18 PhD students. He has published 280 papers and reviews. He was local organiser and chair of the 2013 Metabolomics Conference which was held in Glasgow. Current interests include: mass spectrometric metabolomics in Crohn’s disease, metal toxicity, metabolic syndrome, exercise and immunology.